Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Soligenix Announces Exclusive Licensing Agreement for Novel Vaccine Adjuvant from BTG Specialty Pharmaceuticals
Friday, April 17, 2020Soligenix Inc a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today that it has executed an agreement for the exclusive worldwide license o...
LegoChem Biosciences and Iksuda Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates
Friday, April 17, 2020LegoChem Biosciences Inc based in Daejeon South Korea announced that it has entered a research collaboration and license agreement with Iksuda Therapeutics Iksuda for the development of antibodydrug conjugates in oncology
ImmunoPrecise Announces Agreement with Janssen
Thursday, April 16, 2020IMMUNOPRECISE ANTIBODIES LTD a global leader in therapeutic antibody discovery and development announced that it through its subsidiary Talem Therapeutics has entered into a research license agreement the Agreement with Janssen Research Development...
TScan Announces Collaboration with Novartis on the Discovery and Development of Novel T Cell Receptor Therapies for the Treatment of Solid Tumors
Thursday, April 16, 2020TScan Therapeutics a biopharmaceutical company focused on the development of T cell receptor TCR therapies which reprogram a patients own T cells to recognize shared cancer targets today announced an agreement with Novartis to discover and develop no...
Applied BioMath Announces Collaboration with OncoMyx Therapeutics for Systems Pharmacology Modeling in Immuno-Oncology
Wednesday, April 15, 2020Applied BioMath LLC the industry leader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development announced a collaboration with OncoMyx Therapeutics a privatelyheld oncolytic immunothe...
Intensity Therapeutics Signs Clinical Collaboration Agreement with Bristol Myers Squibb for Advanced Solid Tumors
Wednesday, April 15, 2020Intensity Therapeutics announced it has entered into a clinical trial collaboration agreement with Bristol Myers Squibb Company The program will evaluate the safety and efficacy of Intensitys lead product INT an investigational novel and potent antic...
Hope Biosciences Receives Second FDA Clearance for a Phase II Clinical Trial for Protection Against COVID-19
Tuesday, April 14, 2020Hope Biosciences a clinical stage biotechnology company focused on developing cellbased therapeutics for acute and chronic disease announced that FDA has approved a Phase II clinical trial evaluating the safety and efficacy of Hope Biosciences alloge...
ThermoGenesis Announces Its ImmuneCyte Joint Venture Acquires Key Technologies to Develop Fully Human Polyclonal and Monoclonal Antibody Therapeutics for COVID-19
Tuesday, April 14, 2020ThermoGenesis Holdings Inc a market leader in automated cell processing tools and services in the cell and gene therapy field announced today that its joint venture ImmuneCyte Life Sciences Inc has completed the acquisition of worldwide intellectual...
FDA Approves First Therapy for Children with Debilitating and Disfiguring Rare Disease
Monday, April 13, 2020The US Food and Drug Administration approved Koselugo selumetinib for the treatment of pediatric patients years of age and older with neurofibromatosis type NF a genetic disorder of the nervous system causing tumors to grow on nerves Koselugo is th...
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
Friday, April 10, 2020BioNTech SE and Pfizer Inc disclosed additional details of their collaboration to advance candidates from BioNTechs mRNA vaccine program previously announced on March
